Engineered bacteria reprogram immunosuppressive environments via mechano-NOTCH signaling, indicating novel therapeutic potential.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: